cbdMD, Inc. Fundamental Analysis (AMEX: YCBD-PA)
cbdMD, Inc. Fundamental Analysis (AMEX: YCBD-PA)
cbdMD, Inc. (AMEX: YCBD-PA) shows weak financial fundamentals with a PE ratio of -1.42, profit margin of -13.29%, and ROE of -33.59%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -47.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze YCBD-PA's fundamental strength across five key dimensions:
Efficiency Score
WeakYCBD-PA struggles to generate sufficient returns from assets.
Valuation Score
ExcellentYCBD-PA trades at attractive valuation levels.
Growth Score
WeakYCBD-PA faces weak or negative growth trends.
Financial Health Score
ExcellentYCBD-PA maintains a strong and stable balance sheet.
Profitability Score
WeakYCBD-PA struggles to sustain strong margins.
Key Financial Metrics
Is YCBD-PA Expensive or Cheap?
P/E Ratio
YCBD-PA trades at -1.42 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, YCBD-PA's PEG of -0.02 indicates potential undervaluation.
Price to Book
The market values cbdMD, Inc. at 0.65 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -8.83 times EBITDA. This is generally considered low.
How Well Does YCBD-PA Make Money?
Net Profit Margin
For every $100 in sales, cbdMD, Inc. keeps $-13.29 as profit after all expenses.
Operating Margin
Core operations generate -13.40 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-33.59 in profit for every $100 of shareholder equity.
ROA
cbdMD, Inc. generates $-21.68 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
cbdMD, Inc. generates limited operating cash flow of $-162.84K, signaling weaker underlying cash strength.
Free Cash Flow
cbdMD, Inc. generates weak or negative free cash flow of $-10.93M, restricting financial flexibility.
FCF Per Share
Each share generates $-15.94 in free cash annually.
FCF Yield
YCBD-PA converts -28.03% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-1.42
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.02
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.65
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.30
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.04
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.82
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.34
vs 25 benchmark
ROA
Return on assets percentage
-0.22
vs 25 benchmark
ROCE
Return on capital employed
-0.29
vs 25 benchmark
How YCBD-PA Stacks Against Its Sector Peers
| Metric | YCBD-PA Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -1.42 | 31.50 | Better (Cheaper) |
| ROE | -33.59% | 422.00% | Weak |
| Net Margin | -13.29% | 19867.00% | Weak |
| Debt/Equity | 0.04 | 0.53 | Strong (Low Leverage) |
| Current Ratio | 2.82 | 5.56 | Strong Liquidity |
| ROA | -21.68% | 1571.00% | Weak |
YCBD-PA outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews cbdMD, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation